Comparison of the Pharmacokinetics, Safety, and Tolerability of Two Empagliflozin Formulations in Healthy Korean Subjects.
Xu JiangSungyeun BaeDeok Yong YoonShin Jung ParkJaeseong OhJoo-Youn ChoKyung-Sang YuPublished in: Drug design, development and therapy (2023)
The two formulations of empagliflozin showed similar PK characteristics and were generally well tolerated in healthy subjects.